The mRNA synthesis and manufacturing market is projected to be worth USD 1.5 billion by 2035
Given the current technical and operational challenges associated with the manufacturing of mRNA-based products, innovators in the biopharmaceutical industry are increasingly relying on the mRNA synthesis and contract manufacturing service providers.   Roots Analysis has announced the addition of “mRNA Synthesis and Manufacturing Services Market (2nd Edition), 2022–2035”...
0 Comments 0 Shares